First Manhattan’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $219K | Sell |
3,941
-1,012
| -20% | -$54.8K | ﹤0.01% | 709 |
|
|
2025
Q4 | $245K | Buy |
4,953
+274
| +6% | +$12.8K | ﹤0.01% | 673 |
|
|
2025
Q3 | $204K | Buy |
+4,679
| New | +$183K | ﹤0.01% | 684 |
|
|
2025
Q2 | – | Sell |
-6,019
| Closed | -$236K | – | 710 |
|
|
2025
Q1 | $236K | Sell |
6,019
-3,028
| -33% | -$111K | ﹤0.01% | 628 |
|
|
2024
Q4 | $309K | Hold |
9,047
| – | – | ﹤0.01% | 593 |
|
|
2024
Q3 | $373K | Sell |
9,047
-492
| -5% | -$20.1K | ﹤0.01% | 547 |
|
|
2024
Q2 | $370K | Buy |
9,539
+2,743
| +40% | +$115K | ﹤0.01% | 533 |
|
|
2024
Q1 | $291K | Buy |
6,796
+480
| +8% | +$19.8K | ﹤0.01% | 590 |
|
|
2023
Q4 | $234K | Sell |
6,316
-946
| -13% | -$34K | ﹤0.01% | 619 |
|
|
2023
Q3 | $263K | Sell |
7,262
-4,071
| -36% | -$144K | ﹤0.01% | 612 |
|
|
2023
Q2 | $404K | Hold |
11,333
| – | – | ﹤0.01% | 533 |
|
|
2023
Q1 | $403K | Sell |
11,333
-729
| -6% | -$25.5K | ﹤0.01% | 542 |
|
|
2022
Q4 | $424K | Sell |
12,062
-1,714
| -12% | -$57.1K | ﹤0.01% | 546 |
|
|
2022
Q3 | $405K | Sell |
13,776
-2,084
| -13% | -$79K | ﹤0.01% | 545 |
|
|
2022
Q2 | $862K | Hold |
15,860
| – | – | ﹤0.01% | 436 |
|
|
2022
Q1 | $863K | Sell |
15,860
-36
| -0.2% | -$1.96K | ﹤0.01% | 468 |
|
|
2021
Q4 | $876K | Buy |
15,896
+2,080
| +15% | +$108K | ﹤0.01% | 452 |
|
|
2021
Q3 | $659K | Sell |
13,816
-544
| -4% | -$27.3K | ﹤0.01% | 499 |
|
|
2021
Q2 | $714K | Sell |
14,360
-561
| -4% | -$27K | ﹤0.01% | 483 |
|
|
2021
Q1 | $665K | Sell |
14,921
-776
| -5% | -$35.2K | ﹤0.01% | 480 |
|
|
2020
Q4 | $722K | Sell |
15,697
-1,619
| -9% | -$74.4K | ﹤0.01% | 440 |
|
|
2020
Q3 | $814K | Sell |
17,316
-609
| -3% | -$30.5K | ﹤0.01% | 414 |
|
|
2020
Q2 | $913K | Sell |
17,925
-64
| -0.4% | -$3.28K | 0.01% | 405 |
|
|
2020
Q1 | $852K | Buy |
17,989
+1,180
| +7% | +$62.9K | 0.01% | 398 |
|
|
2019
Q4 | $987K | Sell |
16,809
-9,471
| -36% | -$527K | 0.01% | 410 |
|
|
2019
Q3 | $1.4M | Sell |
26,280
-1,260
| -5% | -$64.8K | 0.01% | 366 |
|
|
2019
Q2 | $1.38M | Sell |
27,540
-474
| -2% | -$23.8K | 0.01% | 391 |
|
|
2019
Q1 | $1.46M | Buy |
28,014
+111
| +0.4% | +$5.55K | 0.01% | 379 |
|
|
2018
Q4 | $1.33M | Buy |
27,903
+2,240
| +9% | +$110K | 0.01% | 394 |
|
|
2018
Q3 | $1.29M | Buy |
25,663
+6,656
| +35% | +$338K | 0.01% | 426 |
|
|
2018
Q2 | $957K | Hold |
19,007
| – | – | 0.01% | 450 |
|
|
2018
Q1 | $928K | Sell |
19,007
-1,251
| -6% | -$58.3K | 0.01% | 443 |
|
|
2017
Q4 | $898K | Sell |
20,258
-708
| -3% | -$32.7K | ﹤0.01% | 463 |
|
|
2017
Q3 | $1.06M | Sell |
20,966
-2,010
| -9% | -$102K | 0.01% | 430 |
|
|
2017
Q2 | $1.24M | Sell |
22,976
-6,373
| -22% | -$340K | 0.01% | 403 |
|
|
2017
Q1 | $1.55M | Sell |
29,349
-261
| -0.9% | -$13.2K | 0.01% | 373 |
|
|
2016
Q4 | $1.43M | Sell |
29,610
-5,162
| -15% | -$255K | 0.01% | 375 |
|
|
2016
Q3 | $1.87M | Sell |
34,772
-1,541
| -4% | -$84.5K | 0.01% | 344 |
|
|
2016
Q2 | $1.97M | Buy |
36,313
+1,268
| +4% | +$66.8K | 0.01% | 347 |
|
|
2016
Q1 | $1.78M | Sell |
35,045
-70,778
| -67% | -$3.53M | 0.01% | 347 |
|
|
2015
Q4 | $5.34M | Sell |
105,823
-5,376
| -5% | -$274K | 0.03% | 227 |
|
|
2015
Q3 | $5.34M | Sell |
111,199
-17,985
| -14% | -$936K | 0.03% | 224 |
|
|
2015
Q2 | $6.72M | Sell |
129,184
-11,171
| -8% | -$629K | 0.04% | 216 |
|
|
2015
Q1 | $8.1M | Sell |
140,355
-16,060
| -10% | -$921K | 0.05% | 194 |
|
|
2014
Q4 | $8.36M | Sell |
156,415
-486,869
| -76% | -$27.2M | 0.05% | 192 |
|
|
2014
Q3 | $37M | Sell |
643,284
-557,382
| -46% | -$34.2M | 0.22% | 83 |
|
|
2014
Q2 | $80.3M | Sell |
1,200,666
-24,464
| -2% | -$1.66M | 0.51% | 44 |
|
|
2014
Q1 | $81.8M | Sell |
1,225,130
-58,782
| -5% | -$3.97M | 0.54% | 41 |
|
|
2013
Q4 | $85.7M | Sell |
1,283,912
-9,090
| -0.7% | -$589K | 0.57% | 40 |
|
|
2013
Q3 | $81.1M | Sell |
1,293,002
-18,164
| -1% | -$1.17M | 0.57% | 42 |
|
|
2013
Q2 | $83.8M | Buy |
+1,311,166
| New | +$83.2M | 0.58% | 39 |
|
Other funds holding GSK
JEST
First Manhattan's GSK Position: Q1 2026 in Review
First Manhattan reduced its GSK (GSK) stake by 20% in Q1 2026, selling an estimated $54.8K and leaving 3,941 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #709.
First Manhattan first reported a position in GSK in Q2 2013 and has held it in 51 quarters since. The position peaked at $85.7M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- First Manhattan held 3,941 shares of GSK worth $219K as of Q1 2026.
- First Manhattan sold 1,012 GSK shares in Q1 2026, an estimated $54.8K.
- GSK made up ﹤0.01% of First Manhattan's portfolio in Q1 2026, its #709 holding.
- First Manhattan first reported a position in GSK in Q2 2013 and has held it in 51 quarters since.
- First Manhattan's GSK position peaked at $85.7M in Q4 2013.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.